Corrections to "Cell division autoantigen 1 enhances signaling and the profibrotic effects of transforming growth factor-β in diabetic nephropathy"  by unknown
Cell division autoantigen 1 enhances signaling and the profibrotic effects of transforming growth factor-b in
diabetic nephropathy
Kidney International (2011) 79, 1260; doi:10.1038/ki.2011.62
Correction to: Kidney International (2011) 79, 199–209; doi:10.1038/ki.2010.374; published online 20 October 2010
For the above referenced article, the lower panel of Figure 1a was incorrect. The correct Figure 1a is shown below.
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Figure 1 |Diabetes induces renal fibrosis in spontaneous
hypertensive rats (SHR). (a, b) Paraffin-embedded kidney
sections of SHR with streptozotocin-induced diabetes for 32
weeks (Dia) and age-matched non-diabetic control SHR (Con)
were stained by Masson’s Trichrome method to show
the extracellular matrix (ECM) in blue color (a) and by
immunohistochemical staining using antibodies (1:1000 dilution)
to a-smooth muscle actin (a-SMA) to show a-SMA in brown color
(b), with scale bars of 300mm as shown (original magnification,
 200). A negative control with no primary antibody is shown for
the immunohistochemical staining of an SHR (Ab). Positive
staining was quantified using the Image-Pro Plus program.
Approximately 10 random views were measured per section to
give an average arbitrary unit. A graph of quantification is shown
for ECM (a) and a-SMA (b) in the non-diabetic control (empty bar)
and diabetic (solid bar) groups. (c) mRNA levels of the following
proteins in the kidneys of non-diabetic control (empty bar) and
diabetic SHR (solid bar) groups as determined by quantitative
real-time reverse transcription-PCR are shown: transforming
growth factor (TGF)-b1 (TGFb), TGF-b type I receptor (TbRI), TGF-b
type II receptor (TbRII), connective tissue growth factor (CTGF),
a-SMA, collagen I (COL1), III (COL3), IV (COL4), and fibronectin
(FN). Values are shown as means±s.e. (n¼ 7 for control; n¼ 9 for
diabetic group); s.e. is shown as error bar. *Po0.05 and
**Po0.001 vs the non-diabetic control group.
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